Web  accessibility  for the disabled Home Contact Us Email Us Shopping Cart
AAFA
AAFA Education Advocacy Research
  
AAFA Home Page
ASTHMA ALLERGIES AAFA
AAFA
 
AAFA
AAFA
AAFA
AAFA
You Can Help!
Certification Program
Educational Resources
Ask the Allergist
Find a Chapter
Find a Support Group
Health Professionals
En Español
Newsroom
Contact AAFA
Login


Asthma and Allergy
Foundation of America
1-800-7-ASTHMA
info@aafa.org
AAFA
Research

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995

FDA Approved Drugs

The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. Review descriptions for our medical therapeutic area list to help assist in your search.

Join our Drug Research Updates group on LinkedIn! 

Find out more about the types of drugs included in this listing.

2015

Cardiology/Vascular Diseases

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Family Medicine

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Infections and Infectious Diseases

Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Neurology

Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015

Pediatrics/Neonatology

Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Vaccines

Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

 
Privacy Policy Home Contact Us Asthma Allergies Food Allergies Donate

 

Ask the allergist Shop Our Catalog Donate to AAFA